1. Home
  2. KAI vs SUPN Comparison

KAI vs SUPN Comparison

Compare KAI & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kadant Inc

KAI

Kadant Inc

N/A

Current Price

$323.70

Market Cap

3.4B

Sector

Industrials

ML Signal

N/A

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

N/A

Current Price

$52.96

Market Cap

2.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KAI
SUPN
Founded
1991
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
2.8B
IPO Year
1996
2010

Fundamental Metrics

Financial Performance
Metric
KAI
SUPN
Price
$323.70
$52.96
Analyst Decision
Buy
Strong Buy
Analyst Count
2
5
Target Price
$337.50
$61.60
AVG Volume (30 Days)
169.5K
750.5K
Earning Date
05-26-2026
01-01-0001
Dividend Yield
0.41%
N/A
EPS Growth
N/A
N/A
EPS
8.65
N/A
Revenue
$1,052,248,000.00
$392,755,000.00
Revenue This Year
$13.28
$23.19
Revenue Next Year
$4.87
$17.65
P/E Ratio
$37.92
N/A
Revenue Growth
N/A
N/A
52 Week Low
$244.87
$29.16
52 Week High
$374.20
$59.68

Technical Indicators

Market Signals
Indicator
KAI
SUPN
Relative Strength Index (RSI) 44.28 52.29
Support Level $317.17 $47.95
Resistance Level $346.77 $58.67
Average True Range (ATR) 17.00 2.30
MACD -1.99 -0.02
Stochastic Oscillator 44.68 33.88

Price Performance

Historical Comparison
KAI
SUPN

About KAI Kadant Inc

Kadant Inc. supplies process and engineering equipment for papermaking, recycling, lumber manufacturing, and related industries. The company's three reportable segments are the Flow Control segment which consists of the fluid-handling and doctoring, cleaning, & filtration product lines; the Industrial Processing segment which consists of the wood processing and stock-preparation product lines; and Material handling systems, which provides conveyor-belt equipment for industries such as mining, food processing, and packaging. The company has a geographic presence in the U.S., China, Asia, Germany, Canada, and Others.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

Share on Social Networks: